INC Research

INC Research Shares Clinical Trial Supply Chain Expertise in China for More Cost-Effective Research Programs

Jessica Liu, MD, Joins Regulatory Panel to Discuss Approval Processes and Import Licenses

Raleigh, NC, July 27, 2010 – INC Research ^®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, will feature Dr. Jessica Liu, senior director of Clinical Operations, Asia Pacific, at the Clinical Trials Supply China 2010 conference, July 28-29 in Beijing.

Dr. Liu will participate on the panel discussion “Shortening the Time Taken for Regulatory Approval Processes and Obtaining Licenses to Import Clinical Trial Supplies into China” July 28 at 9:35 a.m. The interactive session will address issues concerning the complex tier of policies and regulations by national, regional and local government authorities and import and export regulations and procedures in China. To understand what might lead to the withdrawal of drug import licenses, she will present quality specifications of investigational drugs in order to receive the licenses.

As the China market grows in importance for clinical trials, supply systems need to become increasingly sophisticated in order to effectively cope with regional nuances on everything from local regulations to temperature-controlled storage and logistics. Clinical Trials Supply China is a focused event aimed to strengthen clinical trial supply chain practices and shorten trial timeline, reduce waste and minimize costs.

For more information on INC Research’s Asia Pacific locations in Beijing, Shanghai, Singapore and Guragaon, India, click here.

About INC Research® Inc.
INC Research is a therapeutically focused contract research organization with a high performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in therapeutic areas of specialty, and in innovative pediatric and women's health trials. The company's The Trusted Process® methodology and therapeutic foresight leads customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, North Carolina. For more information please visit www.incresearch.com.

###